🇺🇸 FDA
Patent

US 11866488

Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety

granted A61KA61K2039/505A61K31/7105

Quick answer

US patent 11866488 (Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety) held by UNIVERSITY OF CONNECTICUT expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61K31/7105, A61K45/06, A61P